A detailed history of Perpetual LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Perpetual LTD holds 12,560 shares of NBIX stock, worth $1.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,560
Previous 6,390 96.56%
Holding current value
$1.58 Million
Previous $880 Million 64.5%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$114.58 - $153.15 $706,958 - $944,935
6,170 Added 96.56%
12,560 $1.45 Billion
Q2 2024

Jul 30, 2024

SELL
$130.86 - $143.19 $53,652 - $58,707
-410 Reduced 6.03%
6,390 $880 Million
Q1 2024

Apr 09, 2024

BUY
$130.4 - $143.74 $1,825 - $2,012
14 Added 0.21%
6,800 $938 Million
Q4 2023

Feb 15, 2024

BUY
$106.07 - $132.76 $719,791 - $900,909
6,786 New
6,786 $894 Million
Q2 2023

Jul 13, 2023

BUY
$89.53 - $104.87 $203,054 - $237,845
2,268 New
2,268 $214 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Perpetual LTD Portfolio

Follow Perpetual LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.